ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,420.26
-0.22%
Dow Jones
40,003.59
0.34%
Gold vs US Dollar
2,413.935
1.50%
Brent Oil
83.76
0.67%
Bitcoin
66,828.32
2.44%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Frequency Therapeutics Inc (FREQ)

  7. Frequency Therapeutics Inc (FREQ) News

Frequency Therapeutics (FREQ)

Frequency Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:FREQ
DateTimeSourceHeadlineSymbolCompany
01/05/202422:18Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:FREQFrequency Therapeutics Inc
29/04/202412:47Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:FREQFrequency Therapeutics Inc
29/04/202412:44Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:FREQFrequency Therapeutics Inc
29/04/202412:42Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:FREQFrequency Therapeutics Inc
26/04/202421:01Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:FREQFrequency Therapeutics Inc
25/04/202400:33Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:FREQFrequency Therapeutics Inc
24/04/202422:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FREQFrequency Therapeutics Inc
24/04/202422:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FREQFrequency Therapeutics Inc
24/04/202422:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FREQFrequency Therapeutics Inc
23/04/202422:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FREQFrequency Therapeutics Inc
22/04/202422:14Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:FREQFrequency Therapeutics Inc
22/04/202422:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FREQFrequency Therapeutics Inc
19/04/202421:06Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:FREQFrequency Therapeutics Inc
18/04/202413:52Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:FREQFrequency Therapeutics Inc
18/04/202413:40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FREQFrequency Therapeutics Inc
28/03/202419:20Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:FREQFrequency Therapeutics Inc
28/03/202404:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FREQFrequency Therapeutics Inc
26/03/202421:09Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:FREQFrequency Therapeutics Inc
26/03/202421:03Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:FREQFrequency Therapeutics Inc
26/03/202420:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FREQFrequency Therapeutics Inc
26/03/202420:02Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:FREQFrequency Therapeutics Inc
06/11/202322:24Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:FREQFrequency Therapeutics Inc
06/11/202322:22Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:FREQFrequency Therapeutics Inc
06/11/202313:51Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FREQFrequency Therapeutics Inc
02/11/202320:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FREQFrequency Therapeutics Inc
25/10/202321:01Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:FREQFrequency Therapeutics Inc
12/10/202321:05Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:FREQFrequency Therapeutics Inc
02/10/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FREQFrequency Therapeutics Inc
29/09/202321:14Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:FREQFrequency Therapeutics Inc
28/09/202311:06Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:FREQFrequency Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:FREQ

Your Recent History

COIN
CSPEUR
Caspian Token
HUOB
GARIUSDT
Gari Network
GATE
COREUSDT
Core
BIT
F20454
Vontobel Financial Produ...
KOSPI
008930
Hanmi Science
NYSE
AVLC
American Century
LSE
DPEA
BTRX
UQCBTC
Uquid Coin
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved